EVIDENCE LIBRARY
Rhinoceros Study Found No Significant Tremor Reduction With Etorphine–Midazolam Immobilization
A veterinary field study tested whether a midazolam-containing regimen reduced muscle tremors. The measured tremor scores did not differ significantly from the comparison regimen.
A veterinary field study tested whether a midazolam-containing regimen reduced muscle tremors. The measured tremor scores did not differ significantly from the comparison regimen.
The tested hypothesis
Twenty-three free-ranging subadult white rhinoceroses received etorphine with either azaperone or midazolam. The investigators scored tremors during immobilization and recorded distance run.
Median tremor scores were the same in both groups, and the between-group difference was not statistically significant. Distance run also did not differ significantly.
A rationale is different from a demonstrated benefit
Midazolam’s muscle-relaxing properties supplied a reason to test the regimen. They did not guarantee improved tremor scores under the conditions of wildlife capture and opioid immobilization.
The small species-specific study does not prove equivalence at every dose or establish human sedation effects. It also cannot determine all physiologic consequences from tremor scores alone. For veterinary forensic interpretation, retain species, capture stress, co-medication, scoring method, and monitoring rather than treating a familiar pharmacologic property as proof of a successful clinical outcome.
Source paper
Original analysis of the supplied journal article, identified as PMC8252159.